Aytu BioPharma Inc (STU:AY20)
€ 2.88 -0.02 (-0.7%) Market Cap: 16.52 Mil Enterprise Value: 13.72 Mil PE Ratio: 0 PB Ratio: 0.58 GF Score: 33/100

Q4 2019 Aytu BioScience Inc Earnings Call Transcript

Sep 26, 2019 / 08:30PM GMT
Release Date Price: €245.04 (-1.87%)
Operator

Good afternoon, everyone. Thank you for joining us for the Aytu BioScience's Year-end and Fourth Quarter Business Update Call for the year ended June 30, 2019. With me this afternoon are Aytu's Chairman and Chief Executive Officer, Josh Disbrow; and Chief Financial Officer, Dave Green. Aytu BioSciences issued a press release earlier this afternoon with details of the company's operational and financial results. A copy of the press release is available on the news page of the company's website at aytubio.com. (Operator Instructions)

Finally, I'd also like to call your attention to the customary safe harbor disclosure regarding forward-looking information. The conference call today will contain certain forward-looking statements including statements regarding the goals, strategies, beliefs, expectations and future potential operating results of Aytu BioSciences. Although management believes these statements are reasonable based on estimates, assumptions and projections as of today, September 26, 2019, these statements are not guarantees of future performance. Time-sensitive information may no longer

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot